Researcher.Life Logo

Drug Development and Registration : Impact Factor & More

eISSN: 2658-5049pISSN: 2305-2066
JournalOpen Access

Key Metrics

CiteScore
0.6
SNIP
0.81
Recommended pre-submission checks
Powered by Paperpal by Editage

Drug Development and Registration Journal Specifications

Overview
Publisher Center of Pharmaceutical Analytics
Language Russian
Publication Time8
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageRussian
Society/Institute/SponsorI.M. Sechenov First Moscow State Medical University (Sechenov University)
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 8
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY
OA statementVisit website
View less

Planning to publish in Drug Development and Registration ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Development and Registration

Pharmacological management of gabaergic neurons survival in ischemic conditions: the role of a novel hydroxypyridine compound
  • 27 Apr 2026
  • Drug development & registration
Development and validation of HPLC-MS/MS technique for the quantitative determination of a new derivative of sydnonymine and its metabolites in rabbit plasma
  • 24 Apr 2026
  • Drug development & registration
Mathematical pharmacokinetics modeling of parenteral depot formulations
  • 10 Apr 2026
  • Drug development & registration
Experience in validating a method for assessing GLP-1R receptor activation in vitro upon stimulation with tirzepatide
  • 3 Apr 2026
  • Drug development & registration
Polyphenolic combinations quantification through ABTS•+ radical cations accumulation kinetics measurement
  • 27 Mar 2026
  • Drug development & registration
Evolution of clinical trials: a comprehensive analysis of ICH E6(R3) and integrated quality management systems in the pharmaceutical industry
  • 20 Mar 2026
  • Drug development & registration
Pharmacological management of gabaergic neurons survival in ischemic conditions: the role of a novel hydroxypyridine compound
  • 27 Apr 2026
  • Drug development & registration
Development and validation of HPLC-MS/MS technique for the quantitative determination of a new derivative of sydnonymine and its metabolites in rabbit plasma
  • 24 Apr 2026
  • Drug development & registration
Mathematical pharmacokinetics modeling of parenteral depot formulations
  • 10 Apr 2026
  • Drug development & registration
Experience in validating a method for assessing GLP-1R receptor activation in vitro upon stimulation with tirzepatide
  • 3 Apr 2026
  • Drug development & registration
Polyphenolic combinations quantification through ABTS•+ radical cations accumulation kinetics measurement
  • 27 Mar 2026
  • Drug development & registration
Evolution of clinical trials: a comprehensive analysis of ICH E6(R3) and integrated quality management systems in the pharmaceutical industry
  • 20 Mar 2026
  • Drug development & registration

FAQs on Drug Development and Registration